Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Figure 6

Randomized controlled trials of bisphosphonates in adverse events. Forest plot showing the odds ratio and 95% confidence interval of the adverse event rates.